NEO
NeogenomicsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NEO Profile
Neogenomics, Inc.
A leading provider of oncology testing and global contract research services
Life Science Tools and Services
10/29/1998
12/10/2012
NASDAQ Stock Exchange
2,200
12-31
Common stock
9490 NeoGenomics Way, Fort Myers, Florida, 33912
--
Neogenomics, Inc., was incorporated in Nevada on October 29, 1988. Specializing in cancer genetics testing and information services, the company provides physicians with one of the most comprehensive oncology-centric testing menus in the world to help them diagnose and treat cancer. The Company's Drug Services Division provides clinical trials and drug development services to pharmaceutical clients. On October 29, 1998, the parent company was incorporated in Nevada as American Communications Enterprises, Inc., and the parent company changed its name to Neogenomics, Inc., on December 14, 2001.
